BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23180209)

  • 1. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.
    Slesser AA; Georgiou P; Brown G; Mudan S; Goldin R; Tekkis P
    Clin Exp Metastasis; 2013 Apr; 30(4):457-70. PubMed ID: 23180209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease.
    Tan EK; Ooi LL
    Ann Acad Med Singap; 2010 Sep; 39(9):719-15. PubMed ID: 20957308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
    Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
    World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
    Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
    Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.
    van der Pool AE; Lalmahomed ZS; Ozbay Y; de Wilt JH; Eggermont AM; Jzermans JN; Verhoef C
    Colorectal Dis; 2010 Oct; 12(10 Online):e229-35. PubMed ID: 19912286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil.
    van der Wal GE; Gouw AS; Kamps JA; Moorlag HE; Bulthuis ML; Molema G; de Jong KP
    Ann Surg; 2012 Jan; 255(1):86-94. PubMed ID: 22156924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis.
    Ng WW; Cheung YS; Wong J; Lee KF; Lai PB
    Asian J Surg; 2009 Oct; 32(4):189-97. PubMed ID: 19892621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
    Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
    Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
    BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.
    Mekenkamp LJ; Koopman M; Teerenstra S; van Krieken JH; Mol L; Nagtegaal ID; Punt CJ
    Br J Cancer; 2010 Jul; 103(2):159-64. PubMed ID: 20551951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-volume vs. segmental CT texture analysis of the liver to assess metachronous colorectal liver metastases.
    Beckers RCJ; Beets-Tan RGH; Schnerr RS; Maas M; da Costa Andrade LA; Beets GL; Dejong CH; Houwers JB; Lambregts DMJ
    Abdom Radiol (NY); 2017 Nov; 42(11):2639-2645. PubMed ID: 28555265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.
    Zheng P; Ren L; Feng Q; Zhu D; Chang W; He G; Ji M; Jian M; Lin Q; Yi T; Wei Y; Xu J
    Cancer Manag Res; 2018; 10():2871-2881. PubMed ID: 30214282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases.
    Schlag P; Hohenberger P; Herfarth C
    Eur J Surg Oncol; 1990 Aug; 16(4):360-5. PubMed ID: 2379594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
    Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
    Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of surgical treatment of synchronous liver metastases from colorectal cancer.
    Taniai N; Yoshida H; Mamada Y; Matsumoto S; Mizuguchi Y; Suzuki H; Furukawa K; Akimaru K; Tajiri T
    J Nippon Med Sch; 2006 Apr; 73(2):82-8. PubMed ID: 16641532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.